Furthermore, using PandaOmics-based TargetID we revealed gene candidates that could be used as targets for drug discovery for more efficient elimination of cancer cells in sarcoma patients with high expression of CEP135 and lower survival probability. This evidence concerns the gene CEP135 and sarcoma.